Dr. Sylvia Kurz
Yale School of Medicine
Now that there is a targeted drug, specifically for a subtype of glioma, patients with this specific mutation (IDH) can avoid unnecessary treatments that come with serious risks.
Dr. Sylvia Kurz Guide to Glioma Care
Patients facing a glioma diagnosis often encounter complex choices about their next steps in treatment.
Here, Dr. Sylvia Kurz helps outline the key considerations for treating the disease. Dr. Sylvia Kurz is Associate Professor of Neurology (Neuro-Oncology) and cares for patients with brain tumors as part of the Chênevert Family Brain Tumor Center at Smilow Cancer Hospital and Yale Cancer Center. Dr. Kurz is an internationally acclaimed neuro-oncologist
Dr. Sylvia Kurz
Yale School of Medicine
Now that there is a targeted drug, specifically for a subtype of glioma, patients with this specific mutation (IDH) can avoid unnecessary treatments that come with serious risks.

Sign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.